Logo image of GRDN

GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:GRDN - US40145W1018 - Common Stock

30.32 USD
-0.62 (-2%)
Last: 1/9/2026, 8:04:00 PM
30.19 USD
-0.13 (-0.43%)
After Hours: 1/9/2026, 8:04:00 PM

GRDN Key Statistics, Chart & Performance

Key Statistics
Market Cap1.92B
Revenue(TTM)1.39B
Net Income(TTM)40.24M
Shares63.32M
Float21.84M
52 Week High37.43
52 Week Low17.78
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.63
PE48.13
Fwd PE31.96
Earnings (Next)03-24 2026-03-24
IPO2024-09-26
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


GRDN short term performance overview.The bars show the price performance of GRDN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40

GRDN long term performance overview.The bars show the price performance of GRDN in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of GRDN is 30.32 USD. In the past month the price increased by 1.34%. In the past year, price increased by 51.6%.

GUARDIAN PHRMCY SERVICES-A / GRDN Daily stock chart

GRDN Latest News, Press Relases and Analysis

GRDN Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.72 101.94B
CI THE CIGNA GROUP 9.82 74.52B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 124.05 22.82B
LH LABCORP HOLDINGS INC 15.92 20.88B
DGX QUEST DIAGNOSTICS INC 17.87 19.40B
GH GUARDANT HEALTH INC N/A 14.19B
DVA DAVITA INC 12.07 7.87B
HIMS HIMS & HERS HEALTH INC 58.69 7.21B
BTSG BRIGHTSPRING HEALTH SERVICES 36.79 6.77B
CHE CHEMED CORP 20.2 6.29B
RDNT RADNET INC 205.79 6.03B
OPCH OPTION CARE HEALTH INC 21.34 5.05B

About GRDN

Company Profile

GRDN logo image Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. The company is headquartered in Atlanta, Georgia and currently employs 3,400 full-time employees. The company went IPO on 2024-09-26. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.

Company Info

GUARDIAN PHRMCY SERVICES-A

300 Galleria Parkway SE, Suite 800

Atlanta GEORGIA US

Employees: 3400

GRDN Company Website

GRDN Investor Relations

Phone: 14048100089

GUARDIAN PHRMCY SERVICES-A / GRDN FAQ

Can you describe the business of GUARDIAN PHRMCY SERVICES-A?

Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. The company is headquartered in Atlanta, Georgia and currently employs 3,400 full-time employees. The company went IPO on 2024-09-26. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.


What is the stock price of GUARDIAN PHRMCY SERVICES-A today?

The current stock price of GRDN is 30.32 USD. The price decreased by -2% in the last trading session.


Does GUARDIAN PHRMCY SERVICES-A pay dividends?

GRDN does not pay a dividend.


How is the ChartMill rating for GUARDIAN PHRMCY SERVICES-A?

GRDN has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


On which exchange is GRDN stock listed?

GRDN stock is listed on the New York Stock Exchange exchange.


What sector and industry does GUARDIAN PHRMCY SERVICES-A belong to?

GUARDIAN PHRMCY SERVICES-A (GRDN) operates in the Health Care sector and the Health Care Providers & Services industry.


What is the outstanding short interest for GUARDIAN PHRMCY SERVICES-A?

The outstanding short interest for GUARDIAN PHRMCY SERVICES-A (GRDN) is 6.24% of its float.


GRDN Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to GRDN. When comparing the yearly performance of all stocks, GRDN is one of the better performing stocks in the market, outperforming 90.41% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

GRDN Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GRDN. Both the profitability and the financial health of GRDN get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GRDN Financial Highlights

Over the last trailing twelve months GRDN reported a non-GAAP Earnings per Share(EPS) of 0.63. The EPS increased by 139.38% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.9%
ROA 10.32%
ROE 21.9%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%107.5%
Sales Q2Q%20.05%
EPS 1Y (TTM)139.38%
Revenue 1Y (TTM)-28.22%

GRDN Forecast & Estimates

10 analysts have analysed GRDN and the average price target is 34.68 USD. This implies a price increase of 14.38% is expected in the next year compared to the current price of 30.32.

For the next year, analysts expect an EPS growth of 164.44% and a revenue growth 17.72% for GRDN


Analysts
Analysts86
Price Target34.68 (14.38%)
EPS Next Y164.44%
Revenue Next Year17.72%

GRDN Ownership

Ownership
Inst Owners57.53%
Ins Owners8.89%
Short Float %6.24%
Short Ratio4.2